Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Debt Ratio (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Debt Ratio for 4 consecutive years, with 0.22 as the latest value for Q2 2025.

  • On a quarterly basis, Debt Ratio rose 16.05% to 0.22 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.22, a 16.05% increase, with the full-year FY2024 number at 0.19, down 10.12% from a year prior.
  • Debt Ratio was 0.22 for Q2 2025 at Centessa Pharmaceuticals, up from 0.21 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.22 in Q2 2025 to a low of 0.12 in Q3 2024.
  • A 4-year average of 0.17 and a median of 0.19 in 2024 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: soared 37.83% in 2023, then tumbled 36.69% in 2024.
  • Centessa Pharmaceuticals' Debt Ratio stood at 0.16 in 2022, then soared by 33.76% to 0.21 in 2023, then fell by 10.12% to 0.19 in 2024, then grew by 17.86% to 0.22 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Debt Ratio are 0.22 (Q2 2025), 0.21 (Q1 2025), and 0.19 (Q4 2024).